tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

CRSP Stock Latest News

Unusually active option classes on open February 18th
The FlyUnusually active option classes on open February 18th
3d ago
MDT
PGY
Crispr Therapeutics price target lowered to $82 from $89 at Citi
PremiumThe Fly
Crispr Therapeutics price target lowered to $82 from $89 at Citi
3d ago
CRSP
Airbnb, Moderna report Q4 results: Morning Buzz
PremiumThe Fly
Airbnb, Moderna report Q4 results: Morning Buzz
7d ago
BA
AMD
Unusually active option classes on open February 14th
PremiumThe Fly
Unusually active option classes on open February 14th
7d ago
PG
TTD
AMD downgraded, Roku upgraded: Wall Street’s top analyst calls
PremiumThe Fly
AMD downgraded, Roku upgraded: Wall Street’s top analyst calls
7d ago
ADI
AMD
Crispr Therapeutics upgraded to Outperform from In Line at Evercore ISI
PremiumThe FlyCrispr Therapeutics upgraded to Outperform from In Line at Evercore ISI
7d ago
CRSP
CRISPR Therapeutics Reports 2024 Results and Clinical Progress
Premium
Company Announcements
CRISPR Therapeutics Reports 2024 Results and Clinical Progress
8d ago
CRSP
Crispr Therapeutics price target lowered to $49 from $53 at Stifel
Premium
The Fly
Crispr Therapeutics price target lowered to $49 from $53 at Stifel
8d ago
CRSP
Q4 Earnings Surprise Greenlights CRISPR Therapeutics Stock Climb
PremiumMarket News
Q4 Earnings Surprise Greenlights CRISPR Therapeutics Stock Climb
8d ago
CRSP
MRNA
Promising Growth Prospects for Crispr Therapeutics AG: Buy Rating Affirmed by Kostas Biliouris
PremiumRatings
Promising Growth Prospects for Crispr Therapeutics AG: Buy Rating Affirmed by Kostas Biliouris
8d ago
CRSP
Crispr Therapeutics Faces Market Challenges Amidst BPCIA Biosimilar Risks
PremiumCompany Announcements
Crispr Therapeutics Faces Market Challenges Amidst BPCIA Biosimilar Risks
9d ago
CRSP
Crispr Therapeutics AG: Advancements and Strategic Partnerships Justify Buy Rating
PremiumRatings
Crispr Therapeutics AG: Advancements and Strategic Partnerships Justify Buy Rating
9d ago
CRSP
CVS Health, Lyft report Q4 results: Morning Buzz
PremiumThe FlyCVS Health, Lyft report Q4 results: Morning Buzz
9d ago
Z
MU
Tesla, Instacart initiated: Wall Street’s top analyst calls
Premium
The Fly
Tesla, Instacart initiated: Wall Street’s top analyst calls
9d ago
RL
EOG
Crispr Therapeutics price target lowered to $48 from $53 at RBC Capital
Premium
The Fly
Crispr Therapeutics price target lowered to $48 from $53 at RBC Capital
9d ago
CRSP
Crispr Therapeutics price target raised to $120 from $100 at Truist
PremiumThe Fly
Crispr Therapeutics price target raised to $120 from $100 at Truist
9d ago
CRSP
Crispr Therapeutics AG: Strong Financial Position and Strategic Advancements Justify Buy Rating
PremiumRatings
Crispr Therapeutics AG: Strong Financial Position and Strategic Advancements Justify Buy Rating
9d ago
CRSP
Crispr Therapeutics upgraded to Hold from Sell at TD Cowen
PremiumThe Fly
Crispr Therapeutics upgraded to Hold from Sell at TD Cowen
9d ago
CRSP
Crispr Therapeutics price target raised to $56 from $55 at Barclays
PremiumThe Fly
Crispr Therapeutics price target raised to $56 from $55 at Barclays
9d ago
CRSP
Crispr Therapeutics AG’s Financial Challenges: Sell Rating Due to Casgevy Program Burden
PremiumRatingsCrispr Therapeutics AG’s Financial Challenges: Sell Rating Due to Casgevy Program Burden
10d ago
CRSP
Crispr Therapeutics AG: Strategic Collaborations and Promising Pipeline Drive ‘Buy’ Rating
Premium
Ratings
Crispr Therapeutics AG: Strategic Collaborations and Promising Pipeline Drive ‘Buy’ Rating
10d ago
CRSP
Crispr Therapeutics reports Q4 EPS (44c)
Premium
The Fly
Crispr Therapeutics reports Q4 EPS (44c)
10d ago
CRSP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >